BUB +40.21%: the infant formula company received FDA approval to sell tins into the US market today. America has been battling a shortage in infant formula after several brands were forced to recall products that had led to bacterial infections in a number of kids while supply chain issues have compounded the problem. As a result, the FDA fast-tracked the process to have seven of Bubs’ products available for sale in the states with 500,000 tins ready for immediate exportation. Bubs have confirmed an additional 750,000 tins would be made available in the coming months while also looking to increase production at their FDA registered facility to triple capacity. Heading into the announcement, Bubs had around 13m shares short sold, contributing to the early spike in the share price.
scroll
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
Close
Tuesday 3rd June – ASX +29pts, IEL, 360, TWE
Close
Gerrish: The correction is done, we’re positioning for what comes next
Close
Tuesday 3rd June – Dow up +35pts, SPI up +69pts
Close
Relevant suggested news and content from the site
Video
WATCH
PULSE CHECK WEBINAR: Portfolio positioning towards FY26
FY26 is shaping up as a year where strategic portfolio positioning will matter more than ever. Hear from James Gerrish & Shawn Hickman as they detail MM's current views.
Podcast
LISTEN
Tuesday 3rd June – ASX +29pts, IEL, 360, TWE
Daily Podcast Direct from the Desk
Video
WATCH
Gerrish: The correction is done, we’re positioning for what comes next
The Market Matters lead portfolio manager talks the recent recovery, Trump, gold, and why he thinks there's plenty of opportunities.
Podcast
LISTEN
Tuesday 3rd June – Dow up +35pts, SPI up +69pts
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.
